Ozempic, or Wegovy, is a new class of medication that belongs to GLP-1 agonists. It was first developed as a medication to treat type 2 diabetes, and now we know it also has an indication for weight loss.
Requests for GLP-1 agonists as weight loss drugs have significantly increased. That’s because over 70% of us have a weight problem, and we all also struggle to find an easy solution. So, this is just another tool in the box. We have seen this kind of enthusiasm in the past for any new drug that can be potentially helpful for weight management.
…
We all need to invest in our own health, and the one-size-fits-all approach in the last 20 or 30 years has proven to be not effective. We are all different, it’s not just that we have different genetic background, cultural background, different height, different weight, but we are truly dynamically different, even when we compare ourselves today from yesterday, from 1 week ago.
That’s the reason NIH this year in January launched a first-ever discovery study called Nutrition for Precision Health. The goal actually is testing 12,000 people with one standard meal to see who you are and what your body’s response is.
